SlideShare a Scribd company logo
1 of 51
Non-melanoma Skin Cancers
Ihab Samy
Lecturer of surgical oncology
NCI – Cairo University
Squamous Cell Cancer
Epidemiology
• The second most common skin cancer, ranking
behind basal cell carcinoma (4:1).
• 20% of cutaneous malignancies.
• Generally occurs in mid to late life (usually
after age 40).
• Most commonly affects areas of sun exposure.
• Men are affected more often than women.
• A number of variables must be considered
when evaluating a squamous cell carcinoma.
• They relate to the lesion’s ability to recur
locally and to metastasize:
1. Location.
2. Size.
3. Depth of invasion.
4. Histologic grade.
Location
• The central zone of the face is considered a high
risk area for subclinical extension because of its
anatomy; lesions located in this area are
therefore at high risk for local recurrence.
• Lesions of the temple, dorsum of the hand, lips,
scalp, and penis are associated with a high risk of
metastatic disease. Patients with lesions in these
areas must be carefully examined for evidence of
regional lymphadenopathy.
Size
• The larger the lesion, the greater the chance
for local recurrence. As a consequence,
excision margins are selected according to
tumor size.
• A 4- to 5-mm margin for lesions <2cm in
diameter and a 6- to 9-mm margin for lesions
>2cm in diameter have been recommended.
Depth of invasion and histologic grade
• Invasion into the deep dermis or subcutaneous
tissue and a Broder’s grade 2 or higher are
associated with higher recurrence rates.
• Squamous cell cancers demonstrate a propensity
to invade along perineural planes.
• The immunosuppressed or immunocompromised
patient has an increased risk for local recurrence
or metastasis (typically to regional lymph nodes).
Verrucous squamous cell cancer
• An exophytic wart-like appearance.
• Often arises on the foot or glans penis and
anal canal (giant condyloma of Buschke-
Lowenstein).
• Histologically, there is no invasion of the
dermis.
• Squamous cell carcinomas are generally divided into
spindle cell and acantholytic types.
• Spindle cell tumors may appear similar to malignant
melanoma or superficial malignant fibrocytomas.
• Immunohistologic staining can help make this
differentiation. Squamous cell cancers are positive for
cytokeratin and negative for S-100; melanomas are S-
100-positive and cytokeratin-negative.
• Acantholytic-type squamous cell cancers usually arise
from acantholytic solar keratoses.
Risk Factors
• Cumulative lifetime exposure to sunlight 
Ultraviolet B radiation (290–320mm).
• Whites more than Blacks.
• Scrotal tumors in chimney sweeps (soot is the
causative agent).
• Chronic arsenic exposure.
• Exposure to radiation.
• Compromised immunity.
• Human papilloma virus (HPV) exposure (16 and
18).
• Thermal injury.
• Chronic ulceration.
• Sinus tracts.
• Hidradenitis suppurativa.
• Chronic cutaneous lupus erythematosus.
• Genetic predisposition (xeroderma pigmentosum,
epidermal dysplasia, and recessive dystrophic
epidermolysis bullosa and oculocutaneous
albinism).
• Alcohol and tobacco use.
Treatment
• Excisional therapies
• Superficial ablative therapies.
• Radiation therapy.
Excision
• Wide excision: 4–5 mm margins for lesions <2cm in diameter and
6–9mm for larger lesions.
• Tumors at high risk for local recurrence and metastases are those
>1–2cm in diameter that have invaded the mid-dermis or deeper.
• Those involving cartilage and bone are extremely high risk.
• Squamous cell carcinoma of the lip, ear, temple, and genitalia and
lesions associated with the preexisting conditions previously
discussed are also high risk.
• For these high risk lesions, excision with a frozen section margin
check should be used to assess the adequacy of excision.
Superficial ablative techniques
• Squamous cell carcinoma in situ (Bowen’s
disease).
• Lesions that invade no deeper than the
superficial dermis.
N.B. Tumors that are indurated and have
undermined the skin laterally and those with
associated local pain may be deeply invasive and
should be treated by excision.
1-Curettage and electrodesiccation
• Superficial squamous cell cancers.
• Should not be used for lesions with aggressive
histology, large size, or high risk anatomic
location (central face).
• First, curettage is performed by paring down
the lesion to normal tissue.
• Then electrodesiccation is used to destroy
potential tumor nests at the base.
2-Cryotherapy
• Freezes tissue to -195.5°C with liquid nitrogen.
• Can be used for small lesions (<2cm) on the
eyelid, ear, chest, back, or tip of the nose.
• Also used for recurrent tumors with definable
margins.
• Should not be used for eyelid free margins,
the vermilion border of the lip, ala nasi, scalp,
and tumors >3cm.
Radiation therapy
• Cure rates approach 92%.
• Of particular value in the central face, ear, and forehead,
where excisional therapy is potentially deforming.
• Has the advantage of treating a wide region around the
tumor with excellent local control and good cosmetic
outcome.
• Prior to initiating therapy, a biopsy should be obtained for
both histologic confirmation and evaluation of tumor
thickness.
• Most tumors are treated with a dose of 4000–6000 cGy
to the superficial skin.
• The dose is usually divided over 3–4 weeks to prevent
complications.
• Short term, the most troublesome sequelae after
irradiation is “burn” to the area.
• Long-term sequelae include destruction of hair follicles
and sweat glands, radiation dermatitis leading to
changes in skin pigmentation (hyper- or
hypopigmentation), and the development of radiation-
induced precancerous lesions.
BASAL CELL CANCER
• A malignancy of basaloid epithelial cells and is
the most common cancer, outnumbering
cutaneous squamous cell cancer 4 : 1.
• Most often affects light-skinned people, and
rarely affects those with dark skin.
• Develops mainly on sun-exposed areas, the
incidence varying directly with increasing
accumulated sun exposure and inversely with
increasing skin pigmentation.
Histology
• Several distinctive clinical subtypes that correlate
with histology and biologic potential.
• In addition, these subtypes affect treatment
choices.
• Histologic subtypes include:
1. Nodular basal cell cancer (most common)
2. Morpheaform.
3. Superficial.
4. Fibroepitheliomatous.
5. Infundibulocystic.
Nodular basal cell cancer
• An elevated papule with overlying telangiectasia.
• It can become ulcerated as it enlarges, giving the
appearance of having been nibbled at, leading to its
name “rodent ulcer.”
• Pigmented basal cell cancer is a variant of nodular
basal cell cancer that, because of its dark pigment,
must be differentiated from melanoma.
• This type often occurs in dark-skinned individuals.
Morpheaform or sclerosing basal cell cancers
• Also known as fibrosing or desmoplastic.
• A flat, scar-like appearance.
• Some demonstrate endophytic growth leading to a
true tumor margin that is larger than the visible margin
(should be palpated carefully to assess the true extent
of tissue induration).
• This biologic feature leads to a higher recurrence rate
and makes it considered aggressive.
Superficial basal cell cancers
• Tend to appear on the trunk and extremities.
• They appear as erythematous patches, some
have an overlying patchy scale-like or
pigmented appearance.
• They are the most common type of basal cell
cancer, seen with chronic arsenism and in
radiation fields.
Treatment
• Wide excision (Mohs’ microsurgical therapy).
• Curettage and electrodesiccation
• Cryotherapy.
• Radiation therapy.
Surgical excision
• The margin of excision for basal cell cancers
<1cm in diameter should be 4–5mm wide.
• The margin should be increased up to 9 mm
for aggressive growth pattern basal cell cancer
and those >1cm in diameter.
• Margin checks at the time of excision are
mandatory for optimizing results.
Mohs’ micrographic surgery (MMS)
• Described in 1941 by Frederick Mohs.
• Its main advantages are high cure rates and
minimal tissue loss.
• Its ability to optimize tissue preservation is
important in areas where maintaining
function and cosmetic appearance is difficult,
such as the nose, eyelids, lips, ears, digits, and
genitalia.
Irradiation
• Cure rates of 96% and a favorable cosmetic outcome
for small lesions of the central face including the
eyelids, nose, and lips.
• Radiation dose varies between 100 and 300kV per day
and is given according to several fractionation
schedules.
• Typically, 15–17 fractions are given for tumors <2cm in
diameter, increased to 20–22 fractions for tumors
>2cm in diameter, and increased to 30–33 fractions for
larger lesions involving cartilage.
Cases
1st Case
2nd Case
3rd Case
Thank you

More Related Content

What's hot

Basal cell carcnoma
Basal cell carcnomaBasal cell carcnoma
Basal cell carcnoma
Firas Kassab
 
basal cell carcinoma
basal cell carcinomabasal cell carcinoma
basal cell carcinoma
bhavyalathaa
 
Soft tissue sarcoma
Soft tissue sarcomaSoft tissue sarcoma
Soft tissue sarcoma
Arun Raj
 

What's hot (20)

Skin Cancer
Skin CancerSkin Cancer
Skin Cancer
 
Basal cell carcnoma
Basal cell carcnomaBasal cell carcnoma
Basal cell carcnoma
 
Skin Malignancies BCC SCC MM
Skin Malignancies BCC SCC MMSkin Malignancies BCC SCC MM
Skin Malignancies BCC SCC MM
 
Non-Melanoma Skin Cancer
Non-Melanoma Skin CancerNon-Melanoma Skin Cancer
Non-Melanoma Skin Cancer
 
Skin cancer
Skin cancerSkin cancer
Skin cancer
 
Basal cell carcinoma (BCC)
Basal cell carcinoma (BCC)Basal cell carcinoma (BCC)
Basal cell carcinoma (BCC)
 
basal cell carcinoma
basal cell carcinomabasal cell carcinoma
basal cell carcinoma
 
Skin Cancer
Skin CancerSkin Cancer
Skin Cancer
 
Melanoma
MelanomaMelanoma
Melanoma
 
Recent advances in carcinoma breast
Recent advances in carcinoma breastRecent advances in carcinoma breast
Recent advances in carcinoma breast
 
Malignant melanoma A-Z
Malignant melanoma A-ZMalignant melanoma A-Z
Malignant melanoma A-Z
 
Skin tumors
Skin tumorsSkin tumors
Skin tumors
 
Melanoma
MelanomaMelanoma
Melanoma
 
Squamous cell carcinoma of skin | management -all medical aspects.
Squamous cell carcinoma of skin | management -all medical aspects.Squamous cell carcinoma of skin | management -all medical aspects.
Squamous cell carcinoma of skin | management -all medical aspects.
 
Inflammatory Breast Cancer (IBC) Information
Inflammatory Breast Cancer (IBC) InformationInflammatory Breast Cancer (IBC) Information
Inflammatory Breast Cancer (IBC) Information
 
Soft tissue sarcoma
Soft tissue sarcomaSoft tissue sarcoma
Soft tissue sarcoma
 
Locally advanced breast cancer
Locally advanced breast cancerLocally advanced breast cancer
Locally advanced breast cancer
 
Soft tissue sarcoma
Soft tissue sarcomaSoft tissue sarcoma
Soft tissue sarcoma
 
PROGNOSTIC AND PREDICTIVE FACTORS FOR METASTATIC CARCINOMA BREAST
PROGNOSTIC AND PREDICTIVE FACTORS FOR METASTATIC CARCINOMA BREASTPROGNOSTIC AND PREDICTIVE FACTORS FOR METASTATIC CARCINOMA BREAST
PROGNOSTIC AND PREDICTIVE FACTORS FOR METASTATIC CARCINOMA BREAST
 
Sentinel lymph node breast ca
Sentinel lymph node breast caSentinel lymph node breast ca
Sentinel lymph node breast ca
 

Viewers also liked

Robotic surgery and cancer
Robotic surgery and cancerRobotic surgery and cancer
Robotic surgery and cancer
Dr./ Ihab Samy
 
Rehabilitation of the cancer patient
Rehabilitation of the cancer patientRehabilitation of the cancer patient
Rehabilitation of the cancer patient
Dr./ Ihab Samy
 
Kidney and ureteric tumors
Kidney and ureteric tumorsKidney and ureteric tumors
Kidney and ureteric tumors
Dr./ Ihab Samy
 
Lymphadenectomy for gynecological cancers
Lymphadenectomy for gynecological cancersLymphadenectomy for gynecological cancers
Lymphadenectomy for gynecological cancers
Dr./ Ihab Samy
 
Management of the burst abdomen.ppt
Management of the burst abdomen.pptManagement of the burst abdomen.ppt
Management of the burst abdomen.ppt
Dr./ Ihab Samy
 

Viewers also liked (20)

C:\Fakepath\Skin Cancer
C:\Fakepath\Skin CancerC:\Fakepath\Skin Cancer
C:\Fakepath\Skin Cancer
 
Do i have skin cancer?
Do i have skin cancer?Do i have skin cancer?
Do i have skin cancer?
 
Suboccipital lymphadenectomy for patients with occipital squamous cell carcin...
Suboccipital lymphadenectomy for patients with occipital squamous cell carcin...Suboccipital lymphadenectomy for patients with occipital squamous cell carcin...
Suboccipital lymphadenectomy for patients with occipital squamous cell carcin...
 
Disinfection and sterilization
Disinfection and sterilizationDisinfection and sterilization
Disinfection and sterilization
 
Nodular hyperplasia of the liver
Nodular hyperplasia of the liverNodular hyperplasia of the liver
Nodular hyperplasia of the liver
 
Kidney (Renal Cell) Cancer
Kidney (Renal Cell) CancerKidney (Renal Cell) Cancer
Kidney (Renal Cell) Cancer
 
Robotic surgery and cancer
Robotic surgery and cancerRobotic surgery and cancer
Robotic surgery and cancer
 
Peritoneal surface malignancies
Peritoneal surface malignanciesPeritoneal surface malignancies
Peritoneal surface malignancies
 
Rehabilitation of the cancer patient
Rehabilitation of the cancer patientRehabilitation of the cancer patient
Rehabilitation of the cancer patient
 
Kidney and ureteric tumors
Kidney and ureteric tumorsKidney and ureteric tumors
Kidney and ureteric tumors
 
Renal tumors
Renal tumorsRenal tumors
Renal tumors
 
Lymphadenectomy for gynecological cancers
Lymphadenectomy for gynecological cancersLymphadenectomy for gynecological cancers
Lymphadenectomy for gynecological cancers
 
20 kidney
20 kidney20 kidney
20 kidney
 
Management of the burst abdomen.ppt
Management of the burst abdomen.pptManagement of the burst abdomen.ppt
Management of the burst abdomen.ppt
 
Uterine body tumors.
Uterine body tumors.Uterine body tumors.
Uterine body tumors.
 
Colo rectal carcinoma
Colo rectal carcinomaColo rectal carcinoma
Colo rectal carcinoma
 
Melanoma
MelanomaMelanoma
Melanoma
 
Breast cancer staging
Breast cancer stagingBreast cancer staging
Breast cancer staging
 
Diagnostic Imaging of Renal Tumors
Diagnostic Imaging of Renal TumorsDiagnostic Imaging of Renal Tumors
Diagnostic Imaging of Renal Tumors
 
Renal masses imaging
Renal masses imagingRenal masses imaging
Renal masses imaging
 

Similar to Non melanoma skin cancers

20181110 wound healing richard bodor_basics of wounds, lumps, bumps, and rash...
20181110 wound healing richard bodor_basics of wounds, lumps, bumps, and rash...20181110 wound healing richard bodor_basics of wounds, lumps, bumps, and rash...
20181110 wound healing richard bodor_basics of wounds, lumps, bumps, and rash...
SDGWEP
 

Similar to Non melanoma skin cancers (20)

Malignant-skin-tumors (1).pdf
Malignant-skin-tumors (1).pdfMalignant-skin-tumors (1).pdf
Malignant-skin-tumors (1).pdf
 
Skin malignancy md3
Skin malignancy md3Skin malignancy md3
Skin malignancy md3
 
Basics of wounds, lumps, bumps, and rashes for gwep 2018
Basics of wounds, lumps, bumps, and rashes for gwep 2018Basics of wounds, lumps, bumps, and rashes for gwep 2018
Basics of wounds, lumps, bumps, and rashes for gwep 2018
 
20181110 wound healing richard bodor_basics of wounds, lumps, bumps, and rash...
20181110 wound healing richard bodor_basics of wounds, lumps, bumps, and rash...20181110 wound healing richard bodor_basics of wounds, lumps, bumps, and rash...
20181110 wound healing richard bodor_basics of wounds, lumps, bumps, and rash...
 
Management of skin malignancy
Management of skin malignancyManagement of skin malignancy
Management of skin malignancy
 
Skin malignancy presentation.2023.pptx
Skin malignancy presentation.2023.pptxSkin malignancy presentation.2023.pptx
Skin malignancy presentation.2023.pptx
 
اhead and neck skin cancer
اhead and neck skin cancer اhead and neck skin cancer
اhead and neck skin cancer
 
malignant melanoma
malignant melanomamalignant melanoma
malignant melanoma
 
Oral cancer
Oral cancerOral cancer
Oral cancer
 
Etiopathology and management of Malignant melanoma.pptx
Etiopathology and management of Malignant melanoma.pptxEtiopathology and management of Malignant melanoma.pptx
Etiopathology and management of Malignant melanoma.pptx
 
Melanoma
Melanoma Melanoma
Melanoma
 
Tumor of oral cavity
Tumor of oral cavityTumor of oral cavity
Tumor of oral cavity
 
Skin Cancer disease detailed review and information
Skin Cancer disease detailed review and informationSkin Cancer disease detailed review and information
Skin Cancer disease detailed review and information
 
Skin cancers
Skin cancersSkin cancers
Skin cancers
 
Malignant skin diseases
Malignant skin diseasesMalignant skin diseases
Malignant skin diseases
 
malignant epithelial tumors of oral cavity
malignant epithelial tumors of oral cavitymalignant epithelial tumors of oral cavity
malignant epithelial tumors of oral cavity
 
tumoroforalcavity-.pptx
tumoroforalcavity-.pptxtumoroforalcavity-.pptx
tumoroforalcavity-.pptx
 
Skin Cancer.pptx
Skin Cancer.pptxSkin Cancer.pptx
Skin Cancer.pptx
 
Premalignant lesions of skin
Premalignant lesions of skinPremalignant lesions of skin
Premalignant lesions of skin
 
Cutaneous malignancies.pptx
Cutaneous malignancies.pptxCutaneous malignancies.pptx
Cutaneous malignancies.pptx
 

More from Dr./ Ihab Samy

Tumors of the endocrine system
Tumors of the endocrine systemTumors of the endocrine system
Tumors of the endocrine system
Dr./ Ihab Samy
 
Parapharyngeal space tumours
Parapharyngeal space tumoursParapharyngeal space tumours
Parapharyngeal space tumours
Dr./ Ihab Samy
 
Challenges in breast conserving surgery
Challenges in breast conserving surgeryChallenges in breast conserving surgery
Challenges in breast conserving surgery
Dr./ Ihab Samy
 
Surgical anatomy of salivary glands
Surgical anatomy of salivary glandsSurgical anatomy of salivary glands
Surgical anatomy of salivary glands
Dr./ Ihab Samy
 

More from Dr./ Ihab Samy (18)

Tumors of the endocrine system
Tumors of the endocrine systemTumors of the endocrine system
Tumors of the endocrine system
 
Evaluation of Stapled versus Hand-Sewn Techniques for Colo- Rectal Anastomosi...
Evaluation of Stapled versus Hand-Sewn Techniques for Colo- Rectal Anastomosi...Evaluation of Stapled versus Hand-Sewn Techniques for Colo- Rectal Anastomosi...
Evaluation of Stapled versus Hand-Sewn Techniques for Colo- Rectal Anastomosi...
 
Gastrointestinal Stromal Tumors: A clinicopathologic study of 67 cases.
Gastrointestinal Stromal Tumors: A clinicopathologic study of 67 cases.Gastrointestinal Stromal Tumors: A clinicopathologic study of 67 cases.
Gastrointestinal Stromal Tumors: A clinicopathologic study of 67 cases.
 
Poster 3224 ecco 17
Poster 3224 ecco 17Poster 3224 ecco 17
Poster 3224 ecco 17
 
Impact of dead space closure and lymph vessel ligation during MRM on Post-ope...
Impact of dead space closure and lymph vessel ligation during MRM on Post-ope...Impact of dead space closure and lymph vessel ligation during MRM on Post-ope...
Impact of dead space closure and lymph vessel ligation during MRM on Post-ope...
 
Poster 12 BGICC 2014
Poster 12 BGICC 2014Poster 12 BGICC 2014
Poster 12 BGICC 2014
 
Sentinel lymph node biopsy before neoadjuvant chemotherapy for clinical axill...
Sentinel lymph node biopsy before neoadjuvant chemotherapy for clinical axill...Sentinel lymph node biopsy before neoadjuvant chemotherapy for clinical axill...
Sentinel lymph node biopsy before neoadjuvant chemotherapy for clinical axill...
 
Treatment and early outcome of 11 children with hepatoblastoma.
Treatment and early outcome of 11 children with hepatoblastoma.Treatment and early outcome of 11 children with hepatoblastoma.
Treatment and early outcome of 11 children with hepatoblastoma.
 
Cancer of Oral Cavity Abutting the Mandible; Predictors of Loco-regional Fail...
Cancer of Oral Cavity Abutting the Mandible; Predictors of Loco-regional Fail...Cancer of Oral Cavity Abutting the Mandible; Predictors of Loco-regional Fail...
Cancer of Oral Cavity Abutting the Mandible; Predictors of Loco-regional Fail...
 
Para neoplastic (malignant) syndromes
Para neoplastic (malignant) syndromesPara neoplastic (malignant) syndromes
Para neoplastic (malignant) syndromes
 
Role of endoscopy in git cancers
Role of endoscopy in git cancersRole of endoscopy in git cancers
Role of endoscopy in git cancers
 
Parapharyngeal space tumours
Parapharyngeal space tumoursParapharyngeal space tumours
Parapharyngeal space tumours
 
Challenges in breast conserving surgery
Challenges in breast conserving surgeryChallenges in breast conserving surgery
Challenges in breast conserving surgery
 
Thoracic wall
Thoracic wallThoracic wall
Thoracic wall
 
Calcium homeostasis
Calcium homeostasisCalcium homeostasis
Calcium homeostasis
 
Diaphragm
DiaphragmDiaphragm
Diaphragm
 
Adreno cortical tumors
Adreno cortical tumorsAdreno cortical tumors
Adreno cortical tumors
 
Surgical anatomy of salivary glands
Surgical anatomy of salivary glandsSurgical anatomy of salivary glands
Surgical anatomy of salivary glands
 

Recently uploaded

Difference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac MusclesDifference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac Muscles
MedicoseAcademics
 

Recently uploaded (20)

SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024
 
Intro to disinformation and public health
Intro to disinformation and public healthIntro to disinformation and public health
Intro to disinformation and public health
 
Drug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxDrug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptx
 
See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...
See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...
See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...
 
parliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdfparliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdf
 
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?
 
VIP ℂall Girls Electronic City Bangalore 9079923931 WhatsApp: Me All Time Ser...
VIP ℂall Girls Electronic City Bangalore 9079923931 WhatsApp: Me All Time Ser...VIP ℂall Girls Electronic City Bangalore 9079923931 WhatsApp: Me All Time Ser...
VIP ℂall Girls Electronic City Bangalore 9079923931 WhatsApp: Me All Time Ser...
 
VIP ℂall Girls Kaggadasapura {{ Bangalore }} 6378878445 WhatsApp: Me 24/7 Hou...
VIP ℂall Girls Kaggadasapura {{ Bangalore }} 6378878445 WhatsApp: Me 24/7 Hou...VIP ℂall Girls Kaggadasapura {{ Bangalore }} 6378878445 WhatsApp: Me 24/7 Hou...
VIP ℂall Girls Kaggadasapura {{ Bangalore }} 6378878445 WhatsApp: Me 24/7 Hou...
 
Difference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac MusclesDifference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac Muscles
 
VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...
VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...
VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...
 
Vesu * HiFi ℂall Girls Surat Phone No 8849756361 Elite ℂall Serviℂe Available...
Vesu * HiFi ℂall Girls Surat Phone No 8849756361 Elite ℂall Serviℂe Available...Vesu * HiFi ℂall Girls Surat Phone No 8849756361 Elite ℂall Serviℂe Available...
Vesu * HiFi ℂall Girls Surat Phone No 8849756361 Elite ℂall Serviℂe Available...
 
VIP ℂall Girls Kothanur {{ Bangalore }} 6378878445 WhatsApp: Me 24/7 Hours Se...
VIP ℂall Girls Kothanur {{ Bangalore }} 6378878445 WhatsApp: Me 24/7 Hours Se...VIP ℂall Girls Kothanur {{ Bangalore }} 6378878445 WhatsApp: Me 24/7 Hours Se...
VIP ℂall Girls Kothanur {{ Bangalore }} 6378878445 WhatsApp: Me 24/7 Hours Se...
 
Emerging Markets Documentation for Drug Regulatory Affairs
Emerging Markets Documentation for Drug Regulatory AffairsEmerging Markets Documentation for Drug Regulatory Affairs
Emerging Markets Documentation for Drug Regulatory Affairs
 
VIP ℂall Girls Miyapur Hyderabad 7014168258 WhatsApp: Me All Time Serviℂe Ava...
VIP ℂall Girls Miyapur Hyderabad 7014168258 WhatsApp: Me All Time Serviℂe Ava...VIP ℂall Girls Miyapur Hyderabad 7014168258 WhatsApp: Me All Time Serviℂe Ava...
VIP ℂall Girls Miyapur Hyderabad 7014168258 WhatsApp: Me All Time Serviℂe Ava...
 
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptxCreeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
 
ℂall Girls Chandigarh 💚8868886958 💚ℂall Girls Serviℂe Available Day and Night
ℂall Girls Chandigarh  💚8868886958  💚ℂall Girls Serviℂe Available Day and Nightℂall Girls Chandigarh  💚8868886958  💚ℂall Girls Serviℂe Available Day and Night
ℂall Girls Chandigarh 💚8868886958 💚ℂall Girls Serviℂe Available Day and Night
 
Top 15 Sexiest Pakistani Pornstars with Images & Videos
Top 15 Sexiest Pakistani Pornstars with Images & VideosTop 15 Sexiest Pakistani Pornstars with Images & Videos
Top 15 Sexiest Pakistani Pornstars with Images & Videos
 
💚Independent In Mumbai Escorts Service 💯Call Us 🔝 9920874524 🔝💃Top Class Call...
💚Independent In Mumbai Escorts Service 💯Call Us 🔝 9920874524 🔝💃Top Class Call...💚Independent In Mumbai Escorts Service 💯Call Us 🔝 9920874524 🔝💃Top Class Call...
💚Independent In Mumbai Escorts Service 💯Call Us 🔝 9920874524 🔝💃Top Class Call...
 

Non melanoma skin cancers

  • 1. Non-melanoma Skin Cancers Ihab Samy Lecturer of surgical oncology NCI – Cairo University
  • 3. Epidemiology • The second most common skin cancer, ranking behind basal cell carcinoma (4:1). • 20% of cutaneous malignancies. • Generally occurs in mid to late life (usually after age 40). • Most commonly affects areas of sun exposure. • Men are affected more often than women.
  • 4. • A number of variables must be considered when evaluating a squamous cell carcinoma. • They relate to the lesion’s ability to recur locally and to metastasize: 1. Location. 2. Size. 3. Depth of invasion. 4. Histologic grade.
  • 5. Location • The central zone of the face is considered a high risk area for subclinical extension because of its anatomy; lesions located in this area are therefore at high risk for local recurrence. • Lesions of the temple, dorsum of the hand, lips, scalp, and penis are associated with a high risk of metastatic disease. Patients with lesions in these areas must be carefully examined for evidence of regional lymphadenopathy.
  • 6. Size • The larger the lesion, the greater the chance for local recurrence. As a consequence, excision margins are selected according to tumor size. • A 4- to 5-mm margin for lesions <2cm in diameter and a 6- to 9-mm margin for lesions >2cm in diameter have been recommended.
  • 7. Depth of invasion and histologic grade • Invasion into the deep dermis or subcutaneous tissue and a Broder’s grade 2 or higher are associated with higher recurrence rates. • Squamous cell cancers demonstrate a propensity to invade along perineural planes. • The immunosuppressed or immunocompromised patient has an increased risk for local recurrence or metastasis (typically to regional lymph nodes).
  • 8. Verrucous squamous cell cancer • An exophytic wart-like appearance. • Often arises on the foot or glans penis and anal canal (giant condyloma of Buschke- Lowenstein). • Histologically, there is no invasion of the dermis.
  • 9. • Squamous cell carcinomas are generally divided into spindle cell and acantholytic types. • Spindle cell tumors may appear similar to malignant melanoma or superficial malignant fibrocytomas. • Immunohistologic staining can help make this differentiation. Squamous cell cancers are positive for cytokeratin and negative for S-100; melanomas are S- 100-positive and cytokeratin-negative. • Acantholytic-type squamous cell cancers usually arise from acantholytic solar keratoses.
  • 10. Risk Factors • Cumulative lifetime exposure to sunlight  Ultraviolet B radiation (290–320mm). • Whites more than Blacks. • Scrotal tumors in chimney sweeps (soot is the causative agent). • Chronic arsenic exposure. • Exposure to radiation. • Compromised immunity.
  • 11. • Human papilloma virus (HPV) exposure (16 and 18). • Thermal injury. • Chronic ulceration. • Sinus tracts. • Hidradenitis suppurativa. • Chronic cutaneous lupus erythematosus. • Genetic predisposition (xeroderma pigmentosum, epidermal dysplasia, and recessive dystrophic epidermolysis bullosa and oculocutaneous albinism). • Alcohol and tobacco use.
  • 12. Treatment • Excisional therapies • Superficial ablative therapies. • Radiation therapy.
  • 13. Excision • Wide excision: 4–5 mm margins for lesions <2cm in diameter and 6–9mm for larger lesions. • Tumors at high risk for local recurrence and metastases are those >1–2cm in diameter that have invaded the mid-dermis or deeper. • Those involving cartilage and bone are extremely high risk. • Squamous cell carcinoma of the lip, ear, temple, and genitalia and lesions associated with the preexisting conditions previously discussed are also high risk. • For these high risk lesions, excision with a frozen section margin check should be used to assess the adequacy of excision.
  • 14. Superficial ablative techniques • Squamous cell carcinoma in situ (Bowen’s disease). • Lesions that invade no deeper than the superficial dermis. N.B. Tumors that are indurated and have undermined the skin laterally and those with associated local pain may be deeply invasive and should be treated by excision.
  • 15. 1-Curettage and electrodesiccation • Superficial squamous cell cancers. • Should not be used for lesions with aggressive histology, large size, or high risk anatomic location (central face). • First, curettage is performed by paring down the lesion to normal tissue. • Then electrodesiccation is used to destroy potential tumor nests at the base.
  • 16.
  • 17.
  • 18. 2-Cryotherapy • Freezes tissue to -195.5°C with liquid nitrogen. • Can be used for small lesions (<2cm) on the eyelid, ear, chest, back, or tip of the nose. • Also used for recurrent tumors with definable margins. • Should not be used for eyelid free margins, the vermilion border of the lip, ala nasi, scalp, and tumors >3cm.
  • 19.
  • 20. Radiation therapy • Cure rates approach 92%. • Of particular value in the central face, ear, and forehead, where excisional therapy is potentially deforming. • Has the advantage of treating a wide region around the tumor with excellent local control and good cosmetic outcome. • Prior to initiating therapy, a biopsy should be obtained for both histologic confirmation and evaluation of tumor thickness.
  • 21. • Most tumors are treated with a dose of 4000–6000 cGy to the superficial skin. • The dose is usually divided over 3–4 weeks to prevent complications. • Short term, the most troublesome sequelae after irradiation is “burn” to the area. • Long-term sequelae include destruction of hair follicles and sweat glands, radiation dermatitis leading to changes in skin pigmentation (hyper- or hypopigmentation), and the development of radiation- induced precancerous lesions.
  • 23. • A malignancy of basaloid epithelial cells and is the most common cancer, outnumbering cutaneous squamous cell cancer 4 : 1. • Most often affects light-skinned people, and rarely affects those with dark skin. • Develops mainly on sun-exposed areas, the incidence varying directly with increasing accumulated sun exposure and inversely with increasing skin pigmentation.
  • 24.
  • 25. Histology • Several distinctive clinical subtypes that correlate with histology and biologic potential. • In addition, these subtypes affect treatment choices. • Histologic subtypes include: 1. Nodular basal cell cancer (most common) 2. Morpheaform. 3. Superficial. 4. Fibroepitheliomatous. 5. Infundibulocystic.
  • 26.
  • 27. Nodular basal cell cancer • An elevated papule with overlying telangiectasia. • It can become ulcerated as it enlarges, giving the appearance of having been nibbled at, leading to its name “rodent ulcer.” • Pigmented basal cell cancer is a variant of nodular basal cell cancer that, because of its dark pigment, must be differentiated from melanoma. • This type often occurs in dark-skinned individuals.
  • 28.
  • 29. Morpheaform or sclerosing basal cell cancers • Also known as fibrosing or desmoplastic. • A flat, scar-like appearance. • Some demonstrate endophytic growth leading to a true tumor margin that is larger than the visible margin (should be palpated carefully to assess the true extent of tissue induration). • This biologic feature leads to a higher recurrence rate and makes it considered aggressive.
  • 30.
  • 31.
  • 32. Superficial basal cell cancers • Tend to appear on the trunk and extremities. • They appear as erythematous patches, some have an overlying patchy scale-like or pigmented appearance. • They are the most common type of basal cell cancer, seen with chronic arsenism and in radiation fields.
  • 33.
  • 34. Treatment • Wide excision (Mohs’ microsurgical therapy). • Curettage and electrodesiccation • Cryotherapy. • Radiation therapy.
  • 35. Surgical excision • The margin of excision for basal cell cancers <1cm in diameter should be 4–5mm wide. • The margin should be increased up to 9 mm for aggressive growth pattern basal cell cancer and those >1cm in diameter. • Margin checks at the time of excision are mandatory for optimizing results.
  • 36. Mohs’ micrographic surgery (MMS) • Described in 1941 by Frederick Mohs. • Its main advantages are high cure rates and minimal tissue loss. • Its ability to optimize tissue preservation is important in areas where maintaining function and cosmetic appearance is difficult, such as the nose, eyelids, lips, ears, digits, and genitalia.
  • 37.
  • 38. Irradiation • Cure rates of 96% and a favorable cosmetic outcome for small lesions of the central face including the eyelids, nose, and lips. • Radiation dose varies between 100 and 300kV per day and is given according to several fractionation schedules. • Typically, 15–17 fractions are given for tumors <2cm in diameter, increased to 20–22 fractions for tumors >2cm in diameter, and increased to 30–33 fractions for larger lesions involving cartilage.
  • 39. Cases
  • 41.
  • 42.
  • 43.
  • 45.
  • 46.
  • 47.
  • 49.
  • 50.